Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 58,896 shares at $19.76 ($1.2M) on 2021-11-04, disclosed to the SEC on 2021-11-08.
Open-market sale of $1.2M EWTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.76 | 7,392 | $146K | 12.5% |
| 2 | $19.76 | 7,392 | $146K | 12.5% |
| 3 | $19.62 | 13,036 | $256K | 21.9% |
| 4 | $19.62 | 13,036 | $256K | 21.9% |
| 5 | $20.70 | 6 | $124 | 0.0% |
| 6 | $20.16 | 9,017 |
| $182K |
| 15.6% |
| 7 | $20.16 | 9,017 | $182K | 15.6% |
| Total | $19.82 avg | 58,896 | $1.2M | 100% |
| Filing → |
| EWTX | SELL | 2025-11-13 | $2.1M | — | Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |